既往2019冠状病毒病严重程度与大型住院手术后结局相关
该研究利用美国国家COVID队列协作组数据,纳入2020年1月至2023年2月期间接受大型择期住院手术的387,030例成人患者,其中37,354例(9.7%)术前有COVID-19病史。多因素logistic回归显示,中度和重度SARS-CoV-2感染史即使延迟12周手术仍为术后不良结局的独立危险因素,而轻度COVID-19患者在任何时间点均未增加不良结局风险,接种疫苗可降低呼吸衰竭的比值。
要点
- 中度或重度COVID-19病史是大型择期住院手术后不良结局的独立危险因素,即使延迟12周手术仍存在。
- 轻度COVID-19患者在任何时间点均未显示术后不良结局风险增加。
- 接种疫苗可降低术后呼吸衰竭的比值。
核心结论
- COVID-19对术后结局的影响取决于疾病严重程度,仅中度和重度疾病导致不良结局风险升高。
- 现有围术期政策应更新,纳入对COVID-19疾病严重程度和疫苗接种状态的考量。
研究设计与样本
- 利用美国国家COVID队列协作组(National COVID Cohort Collaborative)数据,纳入2020年1月至2023年2月期间接受大型择期住院手术的成人患者,比较有和无COVID-19病史者的术后结局。
- 研究共纳入387,030例患者,其中37,354例(9.7%)术前诊断为COVID-19。
- 将COVID-19严重程度和从感染到手术的时间分别作为自变量,纳入多因素logistic回归模型。
主要发现
- 在387,030例患者中,37,354例(9.7%)术前有COVID-19诊断。
- 中度或重度SARS-CoV-2感染史即使延迟12周手术,仍为术后不良结局的独立危险因素。
- 轻度COVID-19患者在任何时间点均未显示术后不良结局风险增加。
- 接种疫苗可降低呼吸衰竭的比值。
临床怎么用
- 现有围术期政策应更新,纳入对COVID-19疾病严重程度和疫苗接种状态的考量。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine how the severity of prior history (Hx) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection influences postoperative outcomes after major elective inpatient surgery. BACKGROUND: Surgical guidelines instituted early in the coronavirus disease 2019 (COVID-19) pandemic recommended a delay in surgery of up to 8 weeks after an acute SARS-CoV-2 infection. This was based on the observation of elevated surgical risk after recovery from COVID-19 early in the pandemic. As the pandemic shifts to an endemic phase, it is unclear whether this association remains, especially for those recovering from asymptomatic or mildly symptomatic COVID-19. METHODS: Utilizing the National COVID Cohort Collaborative, we assessed postoperative outcomes for adults with and without a Hx of COVID-19 who underwent major elective inpatient surgery between January 2020 and February 2023. COVID-19 severity and time from infection to surgery were each used as independent variables in multivariable logistic regression models. RESULTS: This study included 387,030 patients, of whom 37,354 (9.7%) were diagnosed with preoperative COVID-19. Hx of COVID-19 was found to be an independent risk factor for adverse postoperative outcomes even after a 12-week delay for patients with moderate and severe SARS-CoV-2 infection. Patients with mild COVID-19 did not have an increased risk of adverse postoperative outcomes at any time point. Vaccination decreased the odds of respiratory failure. CONCLUSIONS: Impact of COVID-19 on postoperative outcomes is dependent on the severity of illness, with only moderate and severe disease leading to a higher risk of adverse outcomes. Existing perioperative policies should be updated to include consideration of COVID-19 disease severity and vaccination status.
引用
- Verhagen NB, SenthilKumar G, Jaraczewski T, et al. Severity of Prior Coronavirus Disease 2019 is Associated With Postoperative Outcomes After Major Inpatient Surgery. Ann Surg. 2023. PMID: 37476995. doi:10.1097/SLA.0000000000006035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。